Neuroderm
neuroderm.com
Actively hiring
Neurology & CNS Therapeutics
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
201-500
employees, estimated range
Backers
1
Foresite Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Foresite Capital Similar startupsby what they do, their industry and backers
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound…
Draupnir Bio is developing new innovative therapies for patients.
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Giving back control to patients with uncontrolled epilepsy. At Neurava, we empower individuals with epilepsy to reclaim their lives with…
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
We are on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases.
News
Post Earnings Coverage as NeuroDerm Reported FY16 Results
Upcoming AWS Coverage on Biogen Post-Earnings Results LONDON, UK / ACCESSWIRE / April 12, 2017 / Active Wall St. announces its post-earnings coverage on NeuroDerm Ltd. (NASDAQ: NDRM ). The Company released ...
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.